Orchard Therapeutics (ORTX) Earnings Date, Estimates & Call Transcripts → 25% of Americans Are In Grave Danger (From Banyan Hill Publishing) (Ad) Free ORTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueORTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ORTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyNvidia needs this one obscure firm In my new investigation, I detail why this is the single most important factor in the future of AI. I explain what this Keystone technology is… why it’s so critical to the future of not just AI but mankind… You must read this new presentation from Porter Stansberry. Orchard Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($5.25) EPSNext Year EPS Consensus Estimate: ($4.85) EPS Orchard Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript11/13/2023Q3 2023($1.30)($0.15)+$1.15($0.15)$6.63 million$6.30 million8/3/2023Q2 2023($1.67)($0.07)+$1.60($0.07)$5.20 million$7.31 million5/15/2023Q1 2023($1.61)($0.12)+$1.49($0.12)$6.48 million$1.24 million3/6/2023Q4 2022($1.80)($0.60)+$1.20($0.60)$5.38 million$6.99 million11/14/2022Q3 2022($2.30)($3.70)($1.40)($0.37)$4.12 million$5.78 million8/4/2022Q2 2022($2.50)($4.00)($1.50)($0.40)$2.70 million$4.37 million Get the Latest News and Ratings for ORTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orchard Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/12/2022Q1 2022($2.50)($3.50)($1.00)($0.35)$4.97 million$5.52 million3/30/2022Q4 2021($2.90)($2.90)-($0.29)$0.65 million$0.48 million 11/4/2021Q3 2021($2.50)($2.90)($0.40)($0.29)$5.82 million$1.19 million8/4/2021Q2 2021($3.20)($2.90)+$0.30($0.29)--5/13/2021Q1 2021($3.30)($3.10)+$0.20($0.31)--3/1/2021Q4 2020($3.40)($3.40)-($0.34)--11/3/2020Q3 2020($4.60)($2.00)+$2.60($0.20)-$2.00 million8/6/2020Q2 2020($4.30)($4.80)($0.50)($0.48)-$0.60 million 5/7/2020Q1 2020($5.00)($5.10)($0.10)($0.51)$0.73 million- 2/27/2020Y 2019($4.40)($4.60)($0.20)($0.46)$1.17 million$0.60 million 11/6/2019Q3($4.30)($3.80)+$0.50($0.38)$0.53 million$1.92 million 8/8/2019Q2 2019($3.60)($5.60)($2.00)($0.56)$0.52 million- Orchard Therapeutics Earnings - Frequently Asked Questions How much revenue does Orchard Therapeutics generate each year? Orchard Therapeutics (NASDAQ:ORTX) has a recorded annual revenue of $22.66 million. How much profit does Orchard Therapeutics generate each year? Orchard Therapeutics (NASDAQ:ORTX) has a recorded net income of -$150.66 million. ORTX has generated -$0.94 earnings per share over the last four quarters. What is Orchard Therapeutics's EPS forecast for next year? Orchard Therapeutics's earnings are expected to grow from ($5.25) per share to ($4.85) per share in the next year. More Earnings Resources from MarketBeat Related Companies: DiaMedica Therapeutics Earnings Results Mural Oncology Earnings Results LianBio Earnings Results Enlivex Therapeutics Earnings Results PolyPid Earnings Results Tenax Therapeutics Earnings Results Processa Pharmaceuticals Earnings Results NeuBase Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:ORTX) was last updated on 6/6/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored[Webinar] Understanding Covered CallsDiscover the details of this option-selling strategy.OIC | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredPOTUS in ‘25 Not Biden/Trump, ButAnd I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchard Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchard Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.